Clinicopathological and immunohistochemical features of extragastrointestinal stromal Tumors: Report of two cases

Surgery Today

Volumn 35, Issue 4, 2005, Pages 336-340

  Nakagawa, Motohito ^a   Akasaka, Yoshikiyo ^b   Kanai, Toshio ^a   Takabayashi, Tsukasa ^a   Miyazawa, Naoto ^a  

^a Hiratsuka City Hospital   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

c kit; CD117; Immunohistochemistry; Interstitial cells of Cajal; Tyrosine kinase receptor

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER SURGERY; CAUSE OF DEATH; CELIAC ANGIOGRAPHY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MALE; TUMOR RECURRENCE;

ABDOMINAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 17644391014     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-004-2932-0     Document Type: Article

References (14)

1. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 2000;13:1134-42.
2. Seidal T, Edvardsson H. Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumors. Histopathology 1999;34:416-24.
3. Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999;23:1109-18.
4. Sakurai S, Hishima T, Takazawa Y, Sano T, Nakajima T, Saito K, et al. Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum. Pathol Int 2001;51:524-31.
5. Reith JD, Goldblum JR, Lyles RH, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 2000; 13:577-85.
6. Fukuda H, Suwa T, Kimura F, Sugiura T, Shinoda T, Kaneko K. Gastrointestinal stromal tumor of the lesser omentum: report of a case. Surg Today 2001;31:715-8.
7. Nakagawa M, Akasaka Y, Kanai T, Yamashita T, Kuroda M, Takayama H, et al. Extragastrointestinal stromal tumor of the greater omentum: case report and review of the literature. Hepato-Gastroenterology 2003;50:691-5.
8. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-80.
9. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052-6.
10. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;153:2008-11.
11. Lecoin L, Gabella G, Le Douarin N. Origin of the c-kit positive interstitial cells in the avian bowel. Development 1996;122:725-33.
12. Young HM, Ciampoli D, Southwell BR, Newgreen DF. Origin of interstitial cells of Cajal in the mouse intestine. Dev Biol 1996;180:97-107.
13. Van Oosterom AT, Judson I, Verweij J, Stroobants S, Di Paola ED, Dimitrijevic S, et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors: a phase I study. Lancet 2001;358:1421-3.
14. Demetri GD, Von Mehren M, Blanke CD, Van den Abbeele AD, Eisenburg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2003;347:472-80.